| 1ECV | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | 878, ACT BindingDB | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1G1F, 1SUG | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | 2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases., Andersen HS, Iversen LF, Jeppesen CB, Branner S, Norris K, Rasmussen HB, Moller KB, Moller NP, J Biol Chem 2000 Mar 10;275(10):7101-8. PMID:10702277 | ||||||||||||||
| Data retrieval |
![]() |
| View 1ECV in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |